Concepedia

James R. Corte

JR

Statistics

Publications

21

Citations

666

H-Index

18

Active since

1990

Affiliations

Bristol-Myers Squibb (United States)(Current)

Biocon (India)

Bristol-Myers Squibb (India)

Syngene International (India)

Bristol-Myers Squibb (Germany)

James R. Corte is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1990–2021

21

Publications

21

Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy

Andrew K. Dilger, Kumar B. Pabbisetty, James R. Corte et al. · Journal of Medicinal Chemistry · 2021 · 93 citations · Full text

Efficient Synthesis of 2-Aryl-6-chloronicotinamides via PXPd2-Catalyzed Regioselective Suzuki Coupling

Wu Yang, Yufeng Wang, James R. Corte · Organic Letters · 2003 · 65 citations

, , +9

Synthesis and Characterization of 3-Arylquinazolinone and 3-Arylquinazolinethione Derivatives as Selective Estrogen Receptor Beta Modulators

Timur Güngör, Ying Chen, Rajasree Golla et al. · Journal of Medicinal Chemistry · 2006 · 60 citations · Full text

Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties

Donald Pinto, Joanne M. Smallheer, James R. Corte et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 40 citations · Full text

, , +11

Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity

Jon J. Hangeland, Todd J. Friends, Karen A. Rossi et al. · Journal of Medicinal Chemistry · 2014 · 38 citations · Full text

, , +22

1–5 of 21